In8bio, Inc.

INAB·NASDAQ·$1.69Share Price as of 11/2·$8MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report06/01/26 8-KCurrent report05/07/26 8-KCurrent report03/12/26 8-KCurrent report02/27/26

Prospectuses and Registrations

S-8Registration of securities for employees08/07/26 424B5Prospectus supplement06/01/26 S-3/AShelf registration (amended)05/18/26 S-8Registration of securities for employees05/07/26 S-8 POSPost-effective amendment (S-8)05/07/26

Proxies

DEF 14ADefinitive proxy03/26/26 DEFA14AAdditional proxy materials03/26/26 DEFR14ADefinitive proxy (revised)04/29/25 DEF 14ADefinitive proxy03/17/25 DEFA14AAdditional proxy materials03/17/25

Ownership

SC 13G/ABeneficial ownership (amended)08/13/26 Form 4Insider transaction05/29/26 SC 13D/ABeneficial ownership (amended)05/29/26 Form 4Insider transaction05/12/26 Form 4Insider transaction05/12/26

Other

EFFECTRequest for effectiveness05/19/26 CORRESPCorrespondence with the SEC05/15/26 ARSAnnual report to shareholders03/26/26 EFFECTRequest for effectiveness01/28/26 UPLOADLetter from the SEC01/27/26